Literature DB >> 17546453

An analysis of the physiological FDG uptake in the stomach with the water gastric distention method.

Kiyohisa Kamimura1, Seigo Fujita, Ryuichi Nishii, Hideyuki Wakamatsu, Shigeki Nagamachi, Tatsuhiko Yano, Mikio Ogita, Yoshiro Umemura, Toshiro Fujimoto, Masayuki Nakajo.   

Abstract

PURPOSE: Physiological FDG uptake in the stomach is a common phenomenon, especially noted at the cardia. Water intake just before scanning will result in gastric distention and thinning of the gastric wall, which in turn may lead to a reduction in the physiological uptake in the gastric wall. In the current study, we investigated whether gastric distention by water intake just before PET imaging reduces physiological FDG uptake in the stomach.
METHODS: The patient population comprised 60 patients who underwent whole-body FDG-PET imaging for cancer screening following gastroscopy performed within the preceding week. All patients took 400 ml of water for hydration and were administered 185 MBq of FDG intravenously. The patients were randomly divided into two groups: a group with additional water intake (AW group; n = 30) and a group without additional water intake (NW group; n = 30). In the AW group, an additional 400 ml of water was given just before PET imaging. For quantitative analysis, the stomach was classified into three areas [upper (U), middle (M) and lower (L)], and the degree of FDG uptake in each area was evaluated using standardised uptake values (SUVs).
RESULTS: In the NW group, the mean SUVs in the U, M and L areas were 2.41 +/- 0.75, 2.28 +/- 0.73 and 1.61 +/- 0.89, respectively, while in the AW group they were 1.82 +/- 0.66, 1.73 +/- 0.56 and 1.48 +/- 0.49, respectively, and 2.21 +/- 0.38 in the oesophago-gastric junction. The mean SUVs in the U and M areas in the AW group were significantly lower than those in the NW group (p < 0.05).
CONCLUSION: Additional water intake just before PET imaging is an effective method for suppressing physiological FDG uptake in the stomach.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17546453     DOI: 10.1007/s00259-007-0477-3

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  8 in total

1.  An analysis of the physiological FDG uptake pattern in the stomach.

Authors:  Hirofumi Koga; Masayuki Sasaki; Yasuo Kuwabara; Kiyohisa Hiraka; Makoto Nakagawa; Koichiro Abe; Koichiro Kaneko; Kazutaka Hayashi; Hiroshi Honda
Journal:  Ann Nucl Med       Date:  2003-12       Impact factor: 2.668

2.  Whole-body positron emission tomography: normal variations, pitfalls, and technical considerations.

Authors:  B A Gordon; F L Flanagan; F Dehdashti
Journal:  AJR Am J Roentgenol       Date:  1997-12       Impact factor: 3.959

3.  Computed tomography of the stomach with water as an oral contrast agent: technique and preliminary results.

Authors:  A L Baert; L Roex; G Marchal; P Hermans; D Dewilde; G Wilms
Journal:  J Comput Assist Tomogr       Date:  1989 Jul-Aug       Impact factor: 1.826

4.  The role of gastric distention in differentiating recurrent tumor from physiologic uptake in the remnant stomach on 18F-FDG PET.

Authors:  Mijin Yun; Hyun Seok Choi; Eunhye Yoo; Jung Kyun Bong; Young Hoon Ryu; Jong Doo Lee
Journal:  J Nucl Med       Date:  2005-06       Impact factor: 10.057

5.  Evaluation of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in gastric carcinoma: relation to histological subtypes, depth of tumor invasion, and glucose transporter-1 expression.

Authors:  Akira Yamada; Kazuhiro Oguchi; Mana Fukushima; Yutaka Imai; Masumi Kadoya
Journal:  Ann Nucl Med       Date:  2006-11       Impact factor: 2.668

Review 6.  Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation.

Authors:  G J Cook; I Fogelman; M N Maisey
Journal:  Semin Nucl Med       Date:  1996-10       Impact factor: 4.446

7.  FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings.

Authors:  Alexander Stahl; Katja Ott; Wolfgang Andreas Weber; Karen Becker; Thomas Link; Jörg-Rüdiger Siewert; Markus Schwaiger; Ulrich Fink
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-11-08       Impact factor: 9.236

Review 8.  Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants.

Authors:  P D Shreve; Y Anzai; R L Wahl
Journal:  Radiographics       Date:  1999 Jan-Feb       Impact factor: 5.333

  8 in total
  10 in total

1.  Performance profile of a FDG-PET cancer screening program for detecting gastric cancer: results from a nationwide Japanese survey.

Authors:  Ryogo Minamimoto; Michio Senda; Seishi Jinnouchi; Takashi Terauchi; Tsuyoshi Yoshida; Tomio Inoue
Journal:  Jpn J Radiol       Date:  2014-02-23       Impact factor: 2.374

2.  Incremental diagnostic utility of gastric distension FDG PET/CT.

Authors:  Pierre-Yves Le Roux; Cuong P Duong; Carlos S Cabalag; Bimal K Parameswaran; Jason Callahan; Rodney J Hicks
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-10-21       Impact factor: 9.236

3.  Effects of a proton pump inhibitor on the physiological accumulation of fluoro-2-deoxy-D-glucose (FDG) in FDG-positron emission tomography.

Authors:  Yasushi Domeki; Erena Yamazaki; Akira Matsuura; Kazuhiro Kitajima; Koji Murakami; Hiroyuki Kato
Journal:  Surg Today       Date:  2012-07-24       Impact factor: 2.549

4.  Imaging peritoneal metastasis of gastric cancer with 18F-fluorothymidine positron emission tomography/computed tomography: a proof-of-concept study.

Authors:  Yoshitaka Honma; Takashi Terauchi; Ukihide Tateishi; Daisuke Kano; Kengo Nagashima; Hirokazu Shoji; Satoru Iwasa; Atsuo Takashima; Ken Kato; Tetsuya Hamaguchi; Narikazu Boku; Yasuhiro Shimada; Yasuhide Yamada
Journal:  Br J Radiol       Date:  2018-06-27       Impact factor: 3.039

Review 5.  Japanese Gastric Cancer Association Task Force for Research Promotion: clinical utility of ¹⁸F-fluoro-2-deoxyglucose positron emission tomography in gastric cancer. A systematic review of the literature.

Authors:  Hideaki Shimada; Shinichi Okazumi; Masamichi Koyama; Koji Murakami
Journal:  Gastric Cancer       Date:  2011-02-18       Impact factor: 7.370

6.  Dual time point [18F]Flurodeoxyglucose (FDG) Positron Emission Tomography (PET)/Computed Tomography (CT) with water gastric distension in differentiation between malignant and benign gastric lesions.

Authors:  Hussein Farghaly; Mohamed Alshareef; Abdullah Alqarni; Mohamed Sayed; Hatem Nasr
Journal:  Eur J Radiol Open       Date:  2020-09-07

7.  18F-fluorodeoxyglucose positron emission tomography-computed tomography scan after gastric endoscopy in those who present with non-specific symptoms, is it necessary or not?

Authors:  Haoping Xu; Rui Guo; Weihui Xu; Yanying Pan; Tao Ma
Journal:  South Asian J Cancer       Date:  2017 Apr-Jun

8.  Role in staging and prognostic value of pretherapeutic F-18 FDG PET/CT in patients with gastric MALT lymphoma without high-grade transformation.

Authors:  Yong-Jin Park; Seung Hyup Hyun; Seung Hwan Moon; Kyung-Han Lee; Byung Hoon Min; Jun Haeng Lee; Won Seog Kim; Seok Jin Kim; Joon Young Choi
Journal:  Sci Rep       Date:  2021-04-29       Impact factor: 4.379

9.  Association of esophageal inflammation, obesity and gastroesophageal reflux disease: from FDG PET/CT perspective.

Authors:  Yen-Wen Wu; Ping-Huei Tseng; Yi-Chia Lee; Shan-Ying Wang; Han-Mo Chiu; Chia-Hung Tu; Hsiu-Po Wang; Jaw-Town Lin; Ming-Shiang Wu; Wei-Shiung Yang
Journal:  PLoS One       Date:  2014-03-18       Impact factor: 3.240

Review 10.  The utility of pharmacological and radiological interventions to optimize diagnostic information from PET/CT.

Authors:  David Dudoignon; David A Pattison; Damien Legallois; Rodney J Hicks; Nicolas Aide
Journal:  Cancer Imaging       Date:  2020-09-22       Impact factor: 3.909

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.